Study Start-Up

Trial Interactive's Study Start-Up solution is a configurable platform designed to accelerate clinical trial site activation for study teams, sponsors, and CROs managing complex global trials. By combining process automation, regulatory submission tools, and seamless eTMF integration, it provides a continuous and simplified path from study initiation through to site activation — reducing cycle times and enabling patient recruitment to begin faster.

The platform is purpose-built to eliminate paper-based processes, mitigate obstacles that delay site approvals, and give clinical operations teams real-time visibility into submission and activation progress. Trial Interactive has been shown to expedite clinical trial site selection by up to 35%, making it a critical tool for organizations seeking to improve start-up efficiency across large, multi-site, and global studies.

Core Study Start-Up Capabilities

• Create essential documents and fully configured regulatory submission packages
• Estimate and track deadlines, and predict site activation timelines with accurate forecasting
• Identify missing documents and monitor their statuses throughout the process
• Manage protocol amendments within the platform
• Access forecasting and oversight dashboards with comprehensive reporting
• Identify and address mitigating factors that are delaying site approvals
• Receive alerts highlighting top sites that are ready for activation
• Distribute and submit regulatory packages directly from the platform
• Integrate with Central IRB systems for streamlined submission workflows
• Manage regulatory review workflows and track submission and approval statuses
• Handle milestone and task management across the full start-up lifecycle
• Configure fully customizable QC processes and final packet configurations

Key Benefits for Clinical Study Teams

• Simplify and accelerate the entire process through to site activation
• Streamline regulatory package submission and reduce manual effort
• Accurately forecast start-up milestones and predict approval timelines
• Eliminate paper processes and automate document management and control
• Gain real-time reporting and oversight across all sites and submissions
• Improve collaboration among stakeholders throughout the start-up process
• Reveal bottlenecks in the site activation process before they cause delays
• Reduce compliance risks through structured workflows and document control
• Seamlessly transition from Study Start-Up (SSU) into the eTMF environment
• Receive insights and alerts on document and submission progress

Workflow and Integration Highlights

• Supports global, multi-site trials with centralized document management and automation
• Integrates directly with Trial Interactive's eTMF solution for a continuous, end-to-end trial management experience
• Enables remote inspections through digital document management and regulatory compliance capabilities
• Connects with Central IRB platforms to simplify and accelerate regulatory submissions
• Provides oversight dashboards that give sponsors and CROs full visibility into activation status across all sites

Trial Interactive's Study Start-Up solution is part of a broader suite that includes eTMF and TMF services, content management, trial management, and learning management — offering an integrated platform for end-to-end clinical trial operations. The solution supports regulatory compliance requirements and is designed to scale across complex global studies.